Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Depreciation & Amortization (CF): 2016-2024

Historic Depreciation & Amortization (CF) for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $2.5 million.

  • Solid Biosciences' Depreciation & Amortization (CF) fell 16.87% to $488,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.5 million, marking a year-over-year decrease of 4.88%. This contributed to the annual value of $2.5 million for FY2024, which is 4.88% down from last year.
  • According to the latest figures from FY2024, Solid Biosciences' Depreciation & Amortization (CF) is $2.5 million, which was down 4.88% from $2.6 million recorded in FY2023.
  • Over the past 5 years, Solid Biosciences' Depreciation & Amortization (CF) peaked at $3.9 million during FY2020, and registered a low of $2.4 million during FY2022.
  • In the last 3 years, Solid Biosciences' Depreciation & Amortization (CF) had a median value of $2.5 million in 2024 and averaged $2.5 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 38.88% in 2020, then declined by 24.43% in 2021.
  • Solid Biosciences' Depreciation & Amortization (CF) (Yearly) stood at $3.9 million in 2020, then dropped by 24.43% to $3.0 million in 2021, then decreased by 18.76% to $2.4 million in 2022, then rose by 7.18% to $2.6 million in 2023, then fell by 4.88% to $2.5 million in 2024.